Clinical Cell Culture renames

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.

The resolution to change the company's name was passed by the vast majority of shareholders.

Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.

The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.

Related News

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd